Cresset Asset Management, LLC Ionis Pharmaceuticals Inc Transaction History

Cresset Asset Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 10, 2021	SELL	$34.54 - $47.25 $197,845 - $270,648	-5,728 Closed	0 $0
Q1 2021 May 12, 2021	BUY	$42.51 - $63.78 $243,497 - $365,331	5,728 New	5,728 $258,000
Q2 2019 Aug 12, 2019	SELL	$62.09 - $86.14 $53,707 - $74,511	-865 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$52.92 - $81.17 $5,821 - $8,928	110 Added 14.57%	865 $70,000
Q4 2018 May 21, 2019	BUY	$43.37 - $59.54 $32,744 - $44,952	755 New	755 $41,000

389

125M

2.25M

510K

Ticker IONS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,940,992
Market Cap $5.64B
Description
Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...

Get notified when there are updates to the investment portfolio of Cresset Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Cresset Asset Management, LLC with notifications on news.